Slfn5-KO Mouse
Common Name
Slfn5-KO
제품 ID
S-KO-18874
Backgroud
C57BL/6JCya
품종 계통계통 ID
KOCMP-327978-Slfn5-B6J-VB
상태
이 마우스 계통을 논문에서 사용할 경우, “Slfn5-KO Mouse (카탈로그 번호 S-KO-18874)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Slfn5-KO
품종 계통계통 ID
KOCMP-327978-Slfn5-B6J-VB
유전자명
제품 ID
S-KO-18874
유전자 별칭
--
배경
C57BL/6JCya
NCBI ID
변형 내용
Conventional knockout
염색체
Chr 11
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000067443
NCBI 전사체 ID
NM_183201
타겟 영역
Exon 3
유효 영역 크기
~1.9 kb
유전자 연구 개요
Slfn5, also known as Schlafen 5, is a gene with diverse functions. It is involved in multiple biological processes, such as cell-cycle regulation, DNA repair, and immune response. It is associated with pathways like the AKT/GSK-3β/β-catenin, JAK/STAT, and is important for maintaining genomic stability [5,6,7,8]. Genetic models, especially knockout models, are valuable for studying its functions.
In DNA repair, SLFN5 is crucial for 53BP1 topological arrangement at DNA double-strand breaks (DSBs). SLFN5 deficiency disrupts DSB repair topology and impairs non-homologous end joining, telomere fusions, class switch recombination, and sensitivity to poly (ADP-ribose) polymerase inhibitor [1].
In cancer, in ovarian cancer, SLFN5 promotes reversible epithelial and mesenchymal transformation, and its silencing inhibits EMT and invasion of ovarian cancer cells [3]. In breast cancer, SLFN5 can inhibit cell proliferation and colony formation, promote apoptosis by upregulating PTEN transcription via ZEB1, and inhibit the purine metabolic pathway [7]. In triple-negative breast cancer, histone H4K12 lactylation downregulates SLFN5, promoting malignancy [2]. In castration-resistant prostate cancer, SLFN5 regulates LAT1-mediated mTOR activation [4]. In lung cancer, knockdown of Slfn5 alleviates lipopolysaccharide-induced pneumonia by regulating the JAK/STAT pathway [6]. In colorectal adenocarcinoma, SLFN5 is associated with poor survival outcomes and regulates the immune response via the JAK/STAT/IFN-alpha/beta signaling [8].
In summary, Slfn5 plays essential roles in DNA repair, cell-cycle regulation, and cancer-related processes. The use of gene knockout models in mouse studies has significantly contributed to understanding its functions in these specific disease areas, such as various cancers and DNA repair-related disorders [1,2,3,4,6,7,8].
References:
1. Huang, Jinzhou, Wu, Chenming, Kloeber, Jake A, Yuan, Jian, Lou, Zhenkun. 2023. SLFN5-mediated chromatin dynamics sculpt higher-order DNA repair topology. In Molecular cell, 83, 1043-1060.e10. doi:10.1016/j.molcel.2023.02.004. https://pubmed.ncbi.nlm.nih.gov/36854302/
2. Li, Jingyi, Chen, Ziyu, Jin, Mingming, Zhao, Weiming, Lu, Changlian. 2024. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. In Cellular signalling, 124, 111468. doi:10.1016/j.cellsig.2024.111468. https://pubmed.ncbi.nlm.nih.gov/39395526/
3. Xu, Qiao Ping, Deng, Kui, Zhang, Zhen, Shang, Hongkai. 2023. SLFN5 promotes reversible epithelial and mesenchymal transformation in ovarian cancer. In Journal of ovarian research, 16, 33. doi:10.1186/s13048-023-01103-7. https://pubmed.ncbi.nlm.nih.gov/36747204/
4. Martinez, Rafael S, Salji, Mark J, Rushworth, Linda, Blomme, Arnaud, Leung, Hing Y. 2021. SLFN5 Regulates LAT1-Mediated mTOR Activation in Castration-Resistant Prostate Cancer. In Cancer research, 81, 3664-3678. doi:10.1158/0008-5472.CAN-20-3694. https://pubmed.ncbi.nlm.nih.gov/33985973/
5. Vit, Gianmatteo, Hirth, Alexander, Neugebauer, Nicolas, Nilsson, Jakob, Krämer, Alwin. 2022. Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumption. In Cell death discovery, 8, 484. doi:10.1038/s41420-022-01274-0. https://pubmed.ncbi.nlm.nih.gov/36477080/
6. Wang, Shunying, Li, Li, Wang, Wenming. 2023. Knockdown of Slfn5 alleviates lipopolysaccharide-induced pneumonia by regulating Janus kinase/signal transduction and activator of transcription pathway. In Journal of thoracic disease, 15, 6708-6720. doi:10.21037/jtd-23-889. https://pubmed.ncbi.nlm.nih.gov/38249884/
7. Gu, Xuefeng, Wan, Guoqing, Yang, Yue, Huang, Gang, Lu, Changlian. 2020. SLFN5 influences proliferation and apoptosis by upregulating PTEN transcription via ZEB1 and inhibits the purine metabolic pathway in breast cancer. In American journal of cancer research, 10, 2832-2850. doi:. https://pubmed.ncbi.nlm.nih.gov/33042620/
8. Wu, Yueh-Jung, Chiao, Chung-Chieh, Chuang, Po-Kai, Wang, Chih-Yang, Lee, Yung-Kuo. 2024. Comprehensive analysis of bulk and single-cell RNA sequencing data reveals Schlafen-5 (SLFN5) as a novel prognosis and immunity. In International journal of medical sciences, 21, 2348-2364. doi:10.7150/ijms.97975. https://pubmed.ncbi.nlm.nih.gov/39310264/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
